Director of Regulatory Sciences
Michael (Moshe) Kasser has been involved in the regulation of medical devices since he obtained his Ph.D. in materials science and engineering. His thesis focused on novel materials used in joint replacement, and upon graduation, he immediately put this knowledge to use at the FDA as a scientific reviewer of orthopaedic devices. Michael brought a powerful and unique blend of the regulatory know-how and technical understanding required to comprehend and address the FDA's scientific concerns with novel technologies.
Today, Michael has combined that understanding with a knack for explaining technical concepts in a way that both the industry and FDA can easily understand. He uses his knowledge and communications skills to assist medical device companies to clear FDA hurdles and bring novel technologies to the U.S. market.
While he was at the FDA, Michael focused on novel technologies, such as combination products, Magnetic Resonance Imaging (MRI) safety testing of devices, and new biomaterials. He published articles in both scientific and regulatory journals on a variety of topics.